Skip to main content Accessibility help
×
Home

Intratympanic methylprednisolone injections for subjective tinnitus

  • M Topak (a1), A Sahin-Yilmaz (a1), T Ozdoganoglu (a1), H B Yilmaz (a2), M Ozbay (a1) and M Kulekci (a1)...

Abstract

Objectives:

This study aimed to determine whether intratympanically injected methylprednisolone is effective in treating subjective tinnitus refractory to medical treatment.

Study design:

Prospective, randomised, placebo-controlled, single-blinded study.

Methods:

Seventy adult patients with subjective tinnitus of cochlear origin were randomly assigned to receive intratympanic injection of either methylprednisolone or saline solution. The treatment protocol comprised three intratympanic injections, one per week for three weeks. Improvement in tinnitus severity was measured by a self-rated tinnitus loudness scale and by the tinnitus severity index, at baseline and two weeks after the last injection.

Results:

Data for 59 patients were available for analysis. There was no significant difference between the two treatment groups regarding age, sex, pure tone average, pretreatment tinnitus intensity, tinnitus laterality or tinnitus duration. There was a significant post-treatment improvement in self-rated tinnitus loudness scale results in both groups. No significant post-treatment changes in the tinnitus severity index individual and total scores were observed in either group. The most frequently encountered side effects were pain during injection, vertigo, a burning sensation around the ear and in the throat, and a bitter taste. A burning sensation and bitter taste were observed more often in the methylprednisolone group compared with the placebo group

Conclusion:

The results of this study indicate that intratympanic methylprednisolone has no benefit, compared with placebo, for the treatment of subjective tinnitus of cochlear origin refractory to medical treatment.

Copyright

Corresponding author

Address for correspondence: Dr Asli Sahin-Yilmaz, Taksim Egitim ve Arastirma Hastanesi KBB Klinigi, Cihangir, 34433, Istanbul, Turkey. Fax: 90 212 2499890 E-mail: aslisahin@hotmail.com

Footnotes

Hide All

Presented orally at the 30th Turkish National Congress of Otorhinolaryngology Head and Neck Surgery, 8–12 October 2008, Antalya, Turkey.

Footnotes

References

Hide All
1Shiley, SG, Folmer, RL, McMenomey, SO. Tinnitus and hyperacusis. In: Cummings, CW, Flint, PW, Harker, LA, Haughey, BH, Richardson, MA, Robbins, KT et al. , eds. Otolaryngology Head and Neck Surgery. Philadelphia: Elsevier Mosby, 2005;2832–47
2Hoffer, ME, Wester, D, Kopke, RD, Weisskopf, P, Gottshall, K. Transtympanic management of tinnitus. Otolaryngol Clin North Am 2003;36:353–8
3Alleva, M, Loch, WE, Paparella, MM. Tinnitus. Prim Care 1990;17:289–97
4Dodson, KM, Sismanis, A. Intratympanic perfusion for the treatment of tinnitus. Otolaryngol Clin North Am 2004;37:9911000
5Pitovski, DZ, Drescher, MJ, Drescher, DG. Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 1994;77:216–20
6ten Cate, WJ, Curtis, LM, Small, GM, Rarey, KE. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope 1993;103:865–71
7Shirwany, NA, Seidman, MD, Tang, W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998;19:230–5
8Parnes, LS, Sun, AH, Freeman, DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:117
9Sakata, E, Itoh, A, Itoh, Y. Treatment of cochlear tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996;2:129–35
10Silverstein, H, Isaacson, JE, Olds, MJ, Rowan, PT, Rosenberg, S. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 1998;19:196201
11Araújo, MF, Oliveira, CA, Bahmad, FM Jr.Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005;131:113–17
12Silverstein, H, Choo, D, Rosenberg, SI, Kuhn, J, Seidman, M, Stein, I. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75:468–71, 474, 476
13Barrs, DM. Intratympanic corticosteroids for Meniere's disease and vertigo. Otolaryngol Clin North Am 2004;37:955–72
14Rarey, KE, Curtis, LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:3841
15Schaaf, MJ, Cidlowski, JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002;83:3748
16Banerjee, A, Parnes, LS. The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption. Otolaryngol Clin North Am 2004;37:1035–51
17Fukushima, M, Kitahara, T, Uno, Y, Fuse, Y, Doi, K, Kubo, T. Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol 2002;122:600–6
18Haynes, DS, O'Malley, M, Cohen, S, Watford, K, Labadie, RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:315
19Battista, RA. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:902–5
20Xenellis, J, Papadimitriou, N, Nikolopoulos, T, Maragoudakis, P, Segas, J, Tzagaroulakis, A et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940–5
21Sennaroglu, L, Sennaroglu, G, Gursel, B, Dini, FM. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg 2001;125:537–43
22Shulman, A, Goldstein, B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 2000;6:1020
23Sakata, E, Ito, Y, Itoh, A. Clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J 1997;3:117–21
24Kaltenbach, JA, Afman, CE. Hyperactivity in the dorsal cochlear nucleus after intense sound exposure and its resemblance to tone-evoked activity: a physiological model for tinnitus. Hear Res 2000;140:165–72

Keywords

Intratympanic methylprednisolone injections for subjective tinnitus

  • M Topak (a1), A Sahin-Yilmaz (a1), T Ozdoganoglu (a1), H B Yilmaz (a2), M Ozbay (a1) and M Kulekci (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed